Your browser doesn't support javascript.
loading
The Three-Decade Long Journey in Heart Failure Drug Development.
Lewis, Kelly S; Butler, Javed; Bauersachs, Johann; Sandner, Peter.
Affiliation
  • Lewis KS; Department of Cardiology, Global Medical Affairs, Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA. kelly.lewis@bayer.com.
  • Butler J; Department of Medicine, Division of Cardiovascular Medicine, Stony Brook University, Stony Brook, NY, USA.
  • Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
  • Sandner P; Department of Cardiology, Global Drug Discovery, Bayer Pharma AG, Wuppertal, Germany.
Handb Exp Pharmacol ; 243: 1-14, 2017.
Article in En | MEDLINE | ID: mdl-27995390
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Agents / Heart Failure Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Handb Exp Pharmacol Year: 2017 Document type: Article Affiliation country: United States Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Agents / Heart Failure Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Handb Exp Pharmacol Year: 2017 Document type: Article Affiliation country: United States Country of publication: Germany